Favlyxa (fluorouracil)
New formulation or manufacturer
- Region
- 🇺🇸 US
- Active substance
- fluorouracil
- Company
- Avyxa Holdings
- Status
- Approved
- FDA approval
- Fri 20 Feb 2026
- Designations
- New formulation or manufacturer
- Application
- NDA220201
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Fri 20 Feb 2026🇺🇸 FDA approval
FDA approves Favlyxa (fluorouracil): new formulation or manufacturer
Avyxa Holdings; NDA220201; New formulation or manufacturer; solution · source
Follow Favlyxa
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.